This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Prostate Cancer or Erectile Dysfunction
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to evaluate the use of a hemostatic gelatine-thrombin matrix during athermal nerve-sparing prostate resection compared to conventional hemostasis using electrocautery in patients with localized prostate cancer and to investigate effects on postoperative erectile function and continence.

Provided treatments

  • Procedure: Application of a hemostatic gelatin-thrombin matrix
  • Procedure: Use of mono- and bipolar electrocautery and surgical clips

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01448798. The sponsor of the trial is Johann Wolfgang Goethe University Hospital and it is looking for 50 volunteers for the current phase.
Official trial title:
Prospective Randomized Investigation of Athermal Nerve-sparing During Robotic-assisted Laparoscopic Prostatectomy Using a Hemostatic Gelatin-thrombin Matrix